内镜逆行胰胆管造影术相关不良事件：概述
Endoscopic retrograde cholangiopancreatography-related adverse events: general overview.
作者信息
Rustagi Tarun, Jamidar Priya A
机构信息
Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT 06520, USA.
Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT 06520, USA.
出版信息
Gastrointest Endosc Clin N Am. 2015 Jan;25(1):97-106. doi: 10.1016/j.giec.2014.09.005.
Endoscopic retrograde cholangiopancreatography (ERCP) represents a monumental advance in the management of patients with pancreaticobiliary diseases, but is a complex and technically demanding procedure with the highest inherent risk of adverse events of all routine endoscopic procedures. Overall adverse event rates for ERCP are typically reported as 5-10%. The most commonly reported adverse events include post-ERCP pancreatitis, bleeding, perforation, infection (cholangitis), and cardiopulomary or "sedation related" events. This article evaluates patient-related and procedure-related risk factors for ERCP-related adverse events, and discusses strategies for the prevention, diagnosis and management of these events.
内镜逆行胰胆管造影术（ERCP）是胰胆疾病患者治疗方面的一项重大进展，但它是一项复杂且对技术要求很高的操作，在所有常规内镜操作中发生不良事件的固有风险最高。ERCP的总体不良事件发生率通常报告为5%-10%。最常报告的不良事件包括ERCP术后胰腺炎、出血、穿孔、感染（胆管炎）以及心肺或“镇静相关”事件。本文评估了与ERCP相关不良事件的患者相关和操作相关风险因素，并讨论了这些事件的预防、诊断和管理策略。
Zotero 插件